UBP
BIIB icon

Union Bancaire Privee’s Biogen BIIB Stock Holding History

Union Bancaire Privee’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-82
Closed -$11.3K – 506
2025
Q3 		$11.3K Hold
82
– – ﹤0.01% 455
2025
Q2 		$10.3K Hold
82
– – ﹤0.01% 465
2025
Q1 		$11.3K Hold
82
– – ﹤0.01% 478
2024
Q4 		$12.3K Buy
+82
New +$13.8K ﹤0.01% 530

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Union Bancaire Privee's BIIB Position: Q4 2025 in Review

Union Bancaire Privee sold out of Biogen (BIIB) in Q4 2025, closing a stake of 82 shares — an estimated $11.3K sold.

Union Bancaire Privee first reported a position in BIIB in Q4 2024 and held it in 4 quarters. The position peaked at $12.3K in Q4 2024. 998 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Union Bancaire Privee reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Union Bancaire Privee sold 82 Biogen shares in Q4 2025, an estimated $11.3K.
  • Union Bancaire Privee first reported a position in Biogen in Q4 2024 and held it in 4 quarters.
  • Union Bancaire Privee's Biogen position peaked at $12.3K in Q4 2024.
  • 998 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Union Bancaire Privee's 13F filing for Q4 2025, filed 5 Jan 2026.